Zur Rose Group AG
SIX:ROSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACM Research Shanghai Inc
SSE:688082
|
CN |
|
China BlueChemical Ltd
HKEX:3983
|
CN |
|
K
|
Kyoei Sangyo Co Ltd
TSE:6973
|
JP |
|
T
|
Trigiant Group Ltd
HKEX:1300
|
CN |
|
Kawasaki Heavy Industries Ltd
TSE:7012
|
JP |
|
Ship Healthcare Holdings Inc
TSE:3360
|
JP |
|
B
|
Beijing Sports and Entertainment Industry Group Ltd
HKEX:1803
|
CN |
Zur Rose Group AG
Total Equity
Zur Rose Group AG
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zur Rose Group AG
SIX:ROSE
|
Total Equity
CHf350.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DocMorris AG
SIX:DOCM
|
Total Equity
CHf409.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Zur Rose Group AG
Glance View
Zur Rose Group AG engages in the operation of an e-commerce pharmacy. The company is headquartered in Frauenfeld, Thurgau and currently employs 2,131 full-time employees. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The firm's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The firm operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
See Also
What is Zur Rose Group AG's Total Equity?
Total Equity
350.8m
CHF
Based on the financial report for Dec 31, 2022, Zur Rose Group AG's Total Equity amounts to 350.8m CHF.
What is Zur Rose Group AG's Total Equity growth rate?
Total Equity CAGR 1Y
-28%
Over the last year, the Total Equity growth was -28%.
